Journal article

The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1 beta


Authors listKollewe, C; Neumann, D; Martin, MU

Publication year2000

Pages189-193

JournalFEBS Letters

Volume number487

Issue number2

ISSN0014-5793

DOI Linkhttps://doi.org/10.1016/S0014-5793(00)02345-0

PublisherWiley


Abstract
Two forms of soluble human type II interleukin (IL)-1 receptor (shIL-1RII) were generated, one consisting of the complete extracellular three immunoglobulin (Ig)-like domains and one containing only the first two IV-terminal Ig-like domains. Both forms bound IL-1 beta with a dissociation constant (K-d) Of 200 pM and neutralized IL-1 beta in a bioassay. They did not bind or neutralize IL-1 alpha. This demonstrates that the two Ig-like domains of shIL-1RII are sufficient to bind IL-1 beta with an affinity comparable to full length shIK-1RII. This suggests that this short form of shIL-1RII contributes to the anti-inflammatory effect of soluble IL-1 receptors in vivo. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.



Citation Styles

Harvard Citation styleKollewe, C., Neumann, D. and Martin, M. (2000) The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1 beta, FEBS Letters, 487(2), pp. 189-193. https://doi.org/10.1016/S0014-5793(00)02345-0

APA Citation styleKollewe, C., Neumann, D., & Martin, M. (2000). The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1 beta. FEBS Letters. 487(2), 189-193. https://doi.org/10.1016/S0014-5793(00)02345-0


Last updated on 2025-21-05 at 14:08